Armenian Hamster Anti-NOTCH4 Recombinant Antibody (HMN4-14) (CBMAB-1074-LY)

Guo, M., Zhang, M., Cao, X., Fang, X., Li, K., Qin, L., ... & Li, X. (2022). Notch4 mediates vascular remodeling via ERK/JNK/P38 MAPK signaling pathways in hypoxic pulmonary hypertension. Respiratory Research, 23(1), 1-18.

Muley, A., Kim Uh, M., Salazar-De Simone, G., Swaminathan, B., James, J. M., Murtomaki, A., ... & Shawber, C. J. (2022). Unique functions for Notch4 in murine embryonic lymphangiogenesis. Angiogenesis, 1-20.

Scheurlen, K. M., Chariker, J. H., Kanaan, Z., Littlefield, A. B., George, J. B., Seraphine, C., ... & Galandiuk, S. (2022). The NOTCH4-GATA4-IRG1 axis as a novel target in early-onset colorectal cancer. Cytokine & Growth Factor Reviews.

Xiu, M., Zeng, X., Shan, R., Wen, W., Li, J., & Wan, R. (2021). Targeting Notch4 in cancer: molecular mechanisms and therapeutic perspectives. Cancer Management and Research, 7033-7045.

Long, J., Wang, D., Yang, X., Wang, A., Lin, Y., Zheng, M., ... & Zhao, H. (2021). Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapy. BMC medicine, 19(1), 1-14.

Harb, H., Benamar, M., Lai, P. S., Contini, P., Griffith, J. W., Crestani, E., ... & Chatila, T. A. (2021). Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections. Immunity, 54(6), 1186-1199.

López-López, S., Romero de Ávila, M. J., Hernández de León, N. C., Ruiz-Marcos, F., Baladrón, V., Nueda, M. L., ... & Díaz-Guerra, M. J. M. (2021). NOTCH4 exhibits anti-inflammatory activity in activated macrophages by interfering with interferon-γ and TLR4 signaling. Frontiers in Immunology, 12, 734966.

Harb, H., Stephen-Victor, E., Crestani, E., Benamar, M., Massoud, A., Cui, Y., ... & Chatila, T. A. (2020). A regulatory T cell Notch4–GDF15 axis licenses tissue inflammation in asthma. Nature immunology, 21(11), 1359-1370.

Zhou, L., Wang, D., Sheng, D., Xu, J., Chen, W., Qin, Y., ... & Zhang, L. (2020). NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer. Theranostics, 10(5), 2405.

Lv, H., Nan, Z., Jiang, P., Wang, Z., Song, M., Ding, H., ... & Hu, Y. (2019). Vascular endothelial growth factor 165 inhibits pro-fibrotic differentiation of stromal cells via the DLL4/Notch4/smad7 pathway. Cell Death & Disease, 10(9), 681.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols